ENANTA PHARMACEUTICALS INC's ticker is ENTA and the CUSIP is 29251M106. A total of 183 filers reported holding ENANTA PHARMACEUTICALS INC in Q4 2021. The put-call ratio across all filers is 4.93 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q4 2022 | $329 | -99.9% | 7,080 | -4.8% | 0.03% | -13.2% |
| Q3 2022 | $386,000 | -16.6% | 7,440 | +20.2% | 0.04% | -25.5% |
| Q4 2021 | $463,000 | +59.7% | 6,190 | +103.7% | 0.05% | +6.2% |
| Q1 2019 | $290,000 | -37.4% | 3,039 | -43.8% | 0.05% | -25.0% |
| Q3 2018 | $463,000 | +8.9% | 5,412 | -25.2% | 0.06% | -14.7% |
| Q4 2017 | $425,000 | +105.3% | 7,240 | +2.6% | 0.08% | +33.9% |
| Q1 2016 | $207,000 | – | 7,055 | – | 0.06% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Krensavage Asset Management, LLC | 511,186 | $43,686,000 | 11.23% |
| GREAT POINT PARTNERS LLC | 210,400 | $17,981,000 | 2.80% |
| ARMISTICE CAPITAL, LLC | 456,000 | $38,970,000 | 2.34% |
| Matarin Capital Management, LLC | 210,208 | $17,964,376,000 | 1.16% |
| Sapphire Star Partners LP | 8,168 | $698,000 | 0.70% |
| Granahan Investment Management | 103,320 | $8,830,000 | 0.48% |
| FARALLON CAPITAL MANAGEMENT LLC | 867,500 | $74,137,000 | 0.44% |
| 361 CAPITAL LLC | 19,040 | $1,627,000 | 0.35% |
| ALGERT GLOBAL LLC | 17,922 | $1,532,000 | 0.33% |
| AlphaMark Advisors, LLC | 9,310 | $796,000 | 0.32% |